Clinical Trial Update: A Study to Assess the Short Term Efficacy of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Pain Due to Breast Cancer [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the short-term efficacy of intravenous ibandronate (Bondronat) in participants with metastatic bone pain due to breast cancer; the tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Breast Cancer

Drugs mentioned

• Bondronat (ibandronic acid)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Pain; Bone Neoplasms; Neoplasm Metastasis | Phase 4 | Status: COMPLETED